NCI-4650

N/A

Report date: 2026/05/12 09:09:11

Base Information

Drug NameNCI-4650

Drug Alias NameNCI-4650mRNA-4650

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine > personalized mRNA cancer vaccinesVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUrogenital NeoplasmsLiver NeoplasmsColonic Neoplasms +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc

Inactive CompaniesNational Cancer Institute

Active IndicationsUrogenital NeoplasmsLiver NeoplasmsColorectal Neoplasms +[5]

Inactive IndicationsColonic NeoplasmsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A